Table 1. Baseline Patient Characteristicsa.
| Characteristic | Control Group (n = 81) | Mesh Group (n = 69) |
|---|---|---|
| Age, median (IQR), y | 65 (56.5-70) | 67 (58-72) |
| BMI, mean (SD) | 26.7 (4.8) | 27.6 (4.6) |
| ASA classification | ||
| 1-2 | 19 (23.5) | 18 (26.1) |
| 3 | 55 (67.9) | 47 (68.1) |
| 4 | 7 (8.6) | 4 (5.8) |
| Immunosuppressants or corticosteroid therapy | 3 (3.7) | 4 (5.8) |
| Incisional hernia risk factors | ||
| BMI>25 | 50 (61.7) | 51 (73.9) |
| Diagnosis of neoplastic disease | 67 (82.7) | 54 (78.3) |
| Male | 56 (69.1) | 46 (66.7) |
| Previous laparotomy | 60 (74.1) | 51 (73.9) |
| Type of surgery | ||
| Upper GI tract | 12 (14.8) | 14 (20.3) |
| Lower GI tract | 19 (23.5) | 17 (24.6) |
| Hepatobiliary | 18 (22.2) | 20 (29.0) |
| Pancreatic | 30 (37.0) | 15 (21.7) |
| Other | 2 (2.5) | 3 (4.3) |
| Type of incision | ||
| Midline laparotomy | 30 (37.0) | 31 (44.9) |
| Transverse laparotomy | 51 (63.0) | 38 (55.1) |
| Operation duration, mean (SD), min | 293 (109) | 275 (102) |
| Mesh implantation duration, mean (SD), min | NA | 25 (8) |
Abbreviations: ASA, American Society of Anesthesiologists; BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); GI, gastrointestinal; IQR, interquartile range; NA, not applicable.
a
Data are presented as number (percentage) of patients unless otherwise specified.